- •AstraZeneca
- •Swiss Rockets AG
- •Cancer Research Horizons
- •Sandoz
- •CureVac SE
- •CDR-Life AG
- •Debiopharm
- •Bristol Myers Squibb
- •Netherlands Patent Office
- •CSL
- •Adalvo Ltd
- •Boehringer Ingelheim
- •Galenicum Health
- •Immunocore
- •Novartis
- •Alkermes Pharma Ireland Ltd
- •BioInvent International AB
- •Sandoz Limited
- •Leyden Labs
- •UK BioIndustry Association
- •Germany Patent & Trademark Office
- •Novartis
- •Roche
- •Straumann Group
- •Recordati
- •Debiopharm
- •Genevant Sciences GmbH
- •BAT
- •UPC
- •Leo Pharma
- •Medmix
- •European Patent Office
- •IGI Therapeutics SA
- •Recordati
- •Takeda
- •SHL Medical
- •Syngenta
- •Align Technology
- •Polpharma
- •Valneva
- •Novo Nordisk
- •BIAL
- •Lonza
- •Medmix
- •Telix Pharmaceuticals
- •CSL
- •Bristows LLP
- •Greaves Brewster LLP
- •Neuwerk Partnerschaft
- •Daniel Law
- •D Young and Co LLP
- •Adams and Adams
- •Dannemann Siemsen
- •Griffith Hack
- •Davies Collison Cave
- •RNA Law
- •Rentsch Partner Ltd.
- •Elkington and Fife LLP
- •Carpmaels & Ransford LLP
- •Advokatbyrån Gulliksson AB
- •Hogan Lovells
- •E. Blum and Co. AG
- •Freshfields LLP
- •HOYNG ROKH MONEGIER
- •Lenz and Staehelin
- •Hoffmann Eitle
- •BSKB
- •ATExIPS GmbH / EPI
Global Pharma & Biotech Patent Prosecution and Litigation Strategy Comes Full Circle
28-29 September 2027 | Basel, Switzerland
Europe’s leading content led forum for senior pharmaceutical and biotech IP professionals
2
Days
300
Attendees
1:1
Ratio
Bringing Europe’s Pharma & Biotech IP Community Together
The pharmaceutical and biotech industries are entering a period of unprecedented change.
Patent strategy, litigation, regulatory exclusivity and commercial objectives can no longer operate independently. As the UPC continues to reshape European enforcement, the EU pharmaceutical framework evolves and emerging technologies transform drug development and IP management, businesses must build increasingly sophisticated strategies for protecting and commercialising innovation.
LSPN Europe 2027 will bring together 300+ IP professionals from across the pharmaceutical and biotechnology sectors for two days of practical discussion, strategic insight and high-value networking in Basel — one of Europe’s most important global life sciences hubs.
Meet senior in-house counsel, patent leaders, litigators, regulators and specialist advisers from across the pharma and biotech ecosystem to examine the legal, commercial and strategic developments shaping the future of life sciences IP.
📍 Basel, Switzerland | September 2027
Connecting 300+ Senior IP Leaders across Europe's premier life sciences hub.
Speaking Faculty for 2026 LSPN Europe included:
What You’ll Explore Over Two Days
The 2027 programme will focus on the most important IP challenges facing pharmaceutical and biotechnology companies, including:
300 Senior Pharma & Biotech IP Professionals
LSPN Europe is designed around the quality of the audience, not simply the size of the room.
In September 2027, 300 senior professionals will come together from across:
Pharmaceutical Companies
Global pharma, specialty pharma, generics and emerging pharmaceutical businesses.
Biotechnology Companies
Biologics, cell and gene therapy, RNA, immunotherapy, diagnostics and platform biotechnology companies.
In-House IP Leadership
Chief IP Counsel, Heads of Patents, General Counsel, Patent Counsel and senior IP strategists.
Private Practice & Specialist Advisers
Europe’s leading patent litigators, patent attorneys and specialist life sciences IP advisers.
Courts, Patent Offices & Policy Makers
Decision-makers influencing the future direction of European pharmaceutical and biotech IP.
Who You’ll Meet
Join senior professionals from organisations across the European and global pharma and biotech ecosystem, including:
Why Attend LSPN Europe 2027?
Every discussion is built around the real IP challenges facing pharmaceutical and biotechnology businesses — from early-stage innovation through to market exclusivity and enforcement.
Companies who Attended
Pharma &
Biotech
Institutions &
Healthcare
Law Firms &
Solution Services
The Sponsors who Joined Us in 2026
Coffee Sponsor
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Why This Is The Event For You
End-to-End IP Strategy
Comprehensive coverage spanning across the full patent lifecycle, from initial filing through to enforcement.
Case-Led Practical Learning
Grounded in real-world disputes, landmark court decisions, and actionable legal precedents.
Senior-Level Networking
Connect directly with Chief IP Counsel, General Counsel, and Heads of IP Strategy and Litigation.
Interactive Strategy Circles
Engaging roundtables delivering valuable peer-to-peer insights and key actionable takeaways.
Direct Access to Key Authority
Engage with UPC judges, patent office representatives, and leading practitioners shaping life sciences IP.
Balanced 1:1 Audience Ratio
Maintaining a balanced ratio of in-house counsel to private practice professionals to encourage meaningful networking and knowledge exchange.
Insights from LSPN Europe
Hear directly from key speakers and senior IP leaders about their experiences, key takeaways, and why LSPN Europe is an unmissable event for the sector.
LSPN Europe Highlights
Get a glimpse of the networking, keynote presentations, and insights from our previous event.
Register for LSPN Europe 2027
Join Europe's leading life sciences IP professionals this September in Basel. Register today.
Ayo Fagbohun
Senior Business Development Manager
Newton Media
Rochelle Clarke
Client Engagement Manager
Newton Media
LSPN Europe 2027 is produced by Newton Media
Contact Us
Newton Media
Kingfisher House
21-23 Elmfield Road
Bromley
BR1 1LT
United Kingdom
Email: info@newtonmedia.co.uk
Policies
Cancellation policy Terms of use Privacy policy Code of conduct
© Newton Media Limited 2026
